GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Huahai Pharmaceutical Co Ltd (SHSE:600521) » Definitions » Gross-Profit-to-Asset %

Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Gross-Profit-to-Asset % : 29.39% (As of Mar. 2025)


View and export this data going back to 2003. Start your Free Trial

What is Zhejiang Huahai Pharmaceutical Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Zhejiang Huahai Pharmaceutical Co's annualized Gross Profit for the quarter that ended in Mar. 2025 was ¥6,137 Mil. Zhejiang Huahai Pharmaceutical Co's average Total Assets over the quarter that ended in Mar. 2025 was ¥20,879 Mil. Therefore, Zhejiang Huahai Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 29.39%.


Zhejiang Huahai Pharmaceutical Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Zhejiang Huahai Pharmaceutical Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Huahai Pharmaceutical Co Gross-Profit-to-Asset % Chart

Zhejiang Huahai Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.77 27.97 30.67 27.32 30.42

Zhejiang Huahai Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.86 34.08 27.89 27.51 29.39

Competitive Comparison of Zhejiang Huahai Pharmaceutical Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Huahai Pharmaceutical Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Huahai Pharmaceutical Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Huahai Pharmaceutical Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Zhejiang Huahai Pharmaceutical Co's Gross-Profit-to-Asset % falls into.


;
;

Zhejiang Huahai Pharmaceutical Co Gross-Profit-to-Asset % Calculation

Zhejiang Huahai Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=5910.821/( (18599.97+20261.355)/ 2 )
=5910.821/19430.6625
=30.42 %

Zhejiang Huahai Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=6137.312/( (20261.355+21497.389)/ 2 )
=6137.312/20879.372
=29.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Zhejiang Huahai Pharmaceutical Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Zhejiang Huahai Pharmaceutical Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Huahai Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Xunqiao, Zhejiang Province, Linhai, Linhai, CHN, 317024
Zhejiang Huahai Pharmaceutical Co Ltd is engaged in Research & Development, production and sales of multi-dosage preparations, biological drugs, innovative drugs and specialty APIs.
Executives
Lin Li Hong senior management
Xu Mi senior management
Gang Hui senior management
He Bin senior management
Kong Xiao Fang senior management
Chen Bao Hua Director
Shang Fei senior management
Du Jun Director
Su Yan Director
Chen Dun Yuan senior management
Li Hong Director
Guo Si Jia senior management
Li Min senior management
Xu Bo senior management
Chen Qi Mao senior management

Zhejiang Huahai Pharmaceutical Co Headlines

No Headlines